ABSTRACT
Although a pivotal role of proteasomes in the proteolytic generation of epitopes for major histocompatibility complex (MHC) class I presentation is undisputed, their precise function is currently the subject of an active debate: do proteasomes generate many epitopes in definitive form, or do they merely generate the COOH termini, whereas the definitive NH(2) termini are cleaved by aminopeptidases? We determined five naturally processed MHC class I ligands derived from HIV-1 Nef. Unexpectedly, the five ligands correspond to only three cytotoxic T lymphocyte (CTL) epitopes, two of which occur in two COOH-terminal length variants. Parallel analyses of proteasomal digests of a Nef fragment encompassing the epitopes revealed that all five ligands are direct products of proteasomes. Moreover, in four of the five ligands, the NH(2) termini correspond to major proteasome cleavage sites, and putative NH(2)-terminally extended precursor fragments were detected for only one of the five ligands. All ligands are transported by the transporter associated with antigen processing (TAP). The combined results from these five ligands provide strong evidence that many definitive MHC class I ligands are precisely cleaved at both ends by proteasomes. Additional evidence supporting this conclusion is discussed, along with contrasting results of others who propose a strong role for NH(2)-terminal trimming with direct proteasomal epitope generation being a rare event.
Subject(s)
Cysteine Endopeptidases/metabolism , Epitopes, T-Lymphocyte/immunology , Gene Products, nef/immunology , HIV-1/immunology , Histocompatibility Antigens Class I/immunology , Multienzyme Complexes/metabolism , T-Lymphocytes, Cytotoxic/immunology , ATP Binding Cassette Transporter, Subfamily B, Member 2 , ATP Binding Cassette Transporter, Subfamily B, Member 3 , ATP-Binding Cassette Transporters/immunology , Acetylcysteine/analogs & derivatives , Antigen Presentation/immunology , Cysteine Proteinase Inhibitors , Gene Products, nef/metabolism , HLA-A2 Antigen/immunology , HLA-B7 Antigen/immunology , Humans , Ligands , Peptide Fragments/immunology , Peptides/immunology , Proteasome Endopeptidase Complex , Research Design , nef Gene Products, Human Immunodeficiency VirusABSTRACT
An alanyl-alanyl-phenylalanyl-7-amino-4-methylcoumarin-hydrolyzing protease particle copurifying with 26S proteasomes was isolated and identified as tripeptidyl peptidase II (TPPII), a cytosolic subtilisin-like peptidase of unknown function. The particle is larger than the 26S proteasome and has a rod-shaped, dynamic supramolecular structure. TPPII exhibits enhanced activity in proteasome inhibitor-adapted cells and degrades polypeptides by exo- as well as predominantly trypsin-like endoproteolytic cleavage. TPPII may thus participate in extralysosomal polypeptide degradation and may in part account for nonproteasomal epitope generation as postulated for certain major histocompatibility complex class I alleles. In addition, TPPII may be able to substitute for some metabolic functions of the proteasome.
Subject(s)
Cysteine Endopeptidases/metabolism , Multienzyme Complexes/metabolism , Serine Endopeptidases/metabolism , Acetylcysteine/analogs & derivatives , Acetylcysteine/pharmacology , Alleles , Amino Acid Chloromethyl Ketones/pharmacology , Aminopeptidases , Animals , Cell Survival , Coumarins/metabolism , Cytosol/enzymology , Dipeptidyl-Peptidases and Tripeptidyl-Peptidases , Epitopes/metabolism , Genes, MHC Class I , Hydrolysis , Mice , Molecular Weight , Oligopeptides/metabolism , Proteasome Endopeptidase Complex , Serine Endopeptidases/chemistry , Serine Endopeptidases/isolation & purification , Serine Proteinase Inhibitors/pharmacology , Substrate Specificity , Tumor Cells, CulturedABSTRACT
We have studied polypeptide processing by purified proteasomes, with regard to proteolytic specificity and cytotoxic T-lymphocyte (CTL) epitope generation. Owing to defined preferences with respect to cleavage sites and fragment length, proteasomes degrade polypeptide substrates into cohorts of overlapping oligopeptides. Many of the proteolytic fragments exhibit structural features in common with major histocompatibility complex (MHC) class I ligands including fragment size and frequencies of amino acids at fragment boundaries. Proteasomes frequently generate definitive MHC class I ligands and/or slightly longer peptides, while substantially larger peptides are rare. Individual CTL epitopes are produced in widely varying amounts, often consistent with immunohierarchies among CTL epitopes. We further found that polypeptide processing is remarkably conserved among proteasomes of eukaryotic origin and that invertebrate proteasomes can efficiently produce known high-copy MHC class I ligands, suggesting evolutionary adaptation of the transporter associated with antigen processing and MHC class I to ancient constraints imposed by proteasomal protein degradation.
Subject(s)
Antigen Presentation , Cysteine Endopeptidases/metabolism , Histocompatibility Antigens Class I/metabolism , Multienzyme Complexes/metabolism , ATP-Binding Cassette Transporters/metabolism , Amino Acid Sequence , Animals , Binding Sites/genetics , Biological Evolution , Epitopes/genetics , Epitopes/metabolism , Humans , Ligands , Molecular Sequence Data , Ovalbumin/genetics , Ovalbumin/immunology , Ovalbumin/metabolism , Peptide Fragments/genetics , Peptide Fragments/immunology , Peptide Fragments/metabolism , Proteasome Endopeptidase Complex , Substrate Specificity , T-Lymphocytes, Cytotoxic/immunologyABSTRACT
Herpesvirus saimiri growth-transformed human CD4+ T lymphocytes were examined for their suitability as a target cell system for investigating human immunodeficiency virus (HIV)-specific HLA class I-restricted cytotoxic T-cell activity. Besides CD4, they express the chemokine receptors CCR5 and CXCR4, the common coreceptors of HIV. They are infectible by a range of HIV strains, including primary isolates, becoming efficient targets for CD8-positive HIV-specific cytotoxic T lymphocytes.
Subject(s)
CD4-Positive T-Lymphocytes/immunology , CD4-Positive T-Lymphocytes/virology , CD8-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/virology , Cytotoxicity, Immunologic , HIV-1/immunology , Antigens, Viral , Cell Line, Transformed , Cell Transformation, Viral , HumansSubject(s)
Epitopes, T-Lymphocyte/immunology , Gene Products, nef/immunology , HIV-1/immunology , T-Lymphocytes, Cytotoxic/immunology , Amino Acid Sequence , Epitopes, T-Lymphocyte/chemistry , Gene Products, nef/chemistry , HIV-1/chemistry , HLA-B7 Antigen/immunology , Humans , Molecular Sequence Data , Protein Conformation , nef Gene Products, Human Immunodeficiency VirusABSTRACT
HIV-specific CD8+ cytotoxic T lymphocytes (CTL) are thought to have a beneficial role in HIV infection. In a previous report we have shown that HIV-1 Nef-specific CTL can be readily induced in peripheral blood lymphocytes of seronegative healthy young adults by in vitro stimulation with autologous Epstein-Barr virus-transformed B lymphoblastoid cell lines transfected with the HIV-1 nef gene. Here we demonstrate that these Nef-specific CTL can efficiently lyse HIV-infected primary CD4+ T lymphocytes. CTL of the blood donor tested were Nef-specific and restricted by the autologous MHC class I molecules HLA-A2 and HLA-B7. They recognized HIV-1 Nef in association with both restriction elements but HIV-2 Nef only in association with HLA-B7. The cross-reactivity of the induced effector cells together with the potent immunogenicity of Nef in healthy seronegatives further support the inclusion of Nef as a constituent of HIV vaccines.